Abstract:Inflammatory bowel disease-related colorectal cancer (IBD-CRC) is one of the most serious complications of IBD contributing to significant mortality in this cohort of patients. IBD is often associated with diet and lifestyle-related gut microbial dysbiosis, the interaction of genetic and environmental factors, leading to chronic gut inflammation. According to the "common ground hypothesis", microbial dysbiosis and intestinal barrier impairment are at the core of the chronic inflammatory process associated with IBD-CRC. Among the many underlying factors known to increase the risk of IBD-CRC, perhaps the most important factor is chronic persistent inflammation. The persistent inflammation in the colon results in increased proliferation of cells necessary for repair but this also increases the risk of dysplastic changes due to chromosomal and microsatellite instability. Multiple pathways have been identified, regulated by many positive and negative factors involved in the development of cancer, which in this case follows the 'inflammation-dysplasia-carcinoma' sequence. Strategies to lower this risk are extremely important to reduce morbidity and mortality due to IBD-CRC, among which colonoscopic surveillance is the most widely accepted and implemented modality, forming part of many national and international guidelines. However, the effectiveness of surveillance in IBD has been a topic of much debate in recent years for multiple reasons - cost-benefit to health systems, resource requirements, and also because of studies showing conflicting long-term data. Our review provides a comprehensive overview of past, present, and future perspectives of IBD-CRC. We explore and analyse evidence from studies over decades and current best practices followed globally. In the future directions section, we cover emerging novel endoscopic techniques and artificial intelligence that could play an important role in managing the risk of IBD-CRC.

Colorectal Neoplasia in the Setting of Inflammatory Bowel Disease

Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management

Colorectal cancer in inflammatory bowel disease: review of the evidence

Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis

The Management of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease

Colorectal Cancer In Inflammatory Bowel Disease: Epidemiology, Pathogenesis And Surveillance

Incident Colorectal Cancer in Inflammatory Bowel Disease

Colorectal Cancer in Patients with Inflammatory Bowel Disease: The True Impact of the Risk

Inflammatory Bowel Disease and Colorectal Cancer

Inflammatory bowel disease-related colorectal cancer: Past, present and future perspectives

Colorectal cancer among inflammatory bowel disease patients: risk factors and prevalence compared to the general population

Risk of Colorectal Cancer in Inflammatory Bowel Diseases

Inflammatory Bowel Disease and Colorectal Cancer: Epidemiology, Etiology, Surveillance, and Management

Diagnosis and management of inflammatory bowel disease-associated neoplasia: considerations in the modern era

Reappraising Risk Factors for Inflammatory Bowel Disease-associated Neoplasia: Implications for Colonoscopic Surveillance in IBD

From random to precise: updated colon cancer screening and surveillance for inflammatory bowel disease

Molecular pathways underlying IBD-associated colorectal neoplasia: therapeutic implications

Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk?

A Systematic Review and Meta-Analysis of Endoscopic Surveillance Studies for Detecting Dysplasia in Patients With Inflammatory Bowel Disease

Risk factors for colorectal neoplasia in patients with underlying inflammatory bowel disease: a multicenter study.

Endoscopic approaches to the management of dysplasia in inflammatory bowel disease: A state-of-the-art narrative review